{"id":403330,"date":"2026-08-11T07:02:11","date_gmt":"2026-08-11T07:02:11","guid":{"rendered":"https:\/\/www.newsbeep.com\/us-tx\/403330\/"},"modified":"2026-08-11T07:02:11","modified_gmt":"2026-08-11T07:02:11","slug":"bms-chooses-houston-for-2-3b-manufacturing-facility","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/us-tx\/403330\/","title":{"rendered":"BMS Chooses Houston for $2.3B Manufacturing Facility"},"content":{"rendered":"

\"\"<\/a>A rendering of the $2.3 billion multi-modal manufacturing campus the Bristol Myers Squibb (BMS) plans to build in Houston. BMS says the campus will be designed to support drug product and finished goods manufacturing from late development through launch by producing multiple modalities of treatments. [Bristol Myers Squibb]<\/p>\n

Bristol Myers Squibb (BMS) has selected Houston as the site for a new $2.3 billion multi-modal manufacturing campus designed to support drug product and finished goods manufacturing from late development through launch by producing multiple modalities of treatments\u2014including small molecules, biologics, and antibody-drug conjugates (ADCs)\u2014across disease areas.<\/p>\n

The campus will rise within Generation Park, a 4,300-acre master planned mixed-use campus. BMS\u2019 planned campus is part of the pharma giant\u2019s previously announced commitment to invest $40 billion over five years<\/a> in U.S.-based R&D, technology, and manufacturing.<\/p>\n

\u201cThis investment reflects our confidence in America\u2019s continued leadership in biopharmaceutical innovation,\u201d Christopher Boerner, PhD, BMS\u2019 board chair and CEO, said in a statement. \u201cWe\u2019re building the domestic manufacturing capabilities needed to deliver the next generation of medicines and support future scientific breakthroughs. Houston and the state of Texas offer the talent, infrastructure, and partnership needed to help bring that vision to life.\u201d<\/p>\n

BMS isn\u2019t the only pharma giant to plan a multi-billion-dollar campus at Generation Park. Eli Lilly is developing a $6.5 billion manufacturing site designed to produce active pharmaceutical ingredients for oral drugs\u2014including Foundayo\u00ae (orforglipron), the glucagon-like peptide-1 (GLP-1) receptor agonist obesity drug.<\/p>\n

Lilly grew its regional footprint in April by acquiring Houston startup CrossBridge Bio, a developer of next-generation dual-payload antibody-drug conjugates (ADCs), for up to $300 million.<\/p>\n

Reshoring plans<\/p>\n

Lilly and BMS are among U.S.-based biopharma giants that have announced plans over the past year and a half to reshore significant portions of their manufacturing operations Stateside. Companies have cited a need to meet growing demand for new treatments\u2014and an apparent desire to avoid the 100% tariff on treatments produced outside the United States, a tariff that took effect on July 31 based on Section 232 of the Trade Expansion Act of 1962<\/a>, which allows investigations into whether drug imports by multinational biopharmas threaten national security.<\/p>\n

Section 232 was amended earlier this year to allow a president to impose restrictions on goods imports or enter into negotiations with trading partners if the U.S. Secretary of Commerce determines, following an investigation, that the quantity or other circumstance of those imports \u201cthreaten[s] to impair\u201d U.S. national security.<\/p>\n

The planned Houston campus, BMS said, will be modular in design, enabling the company to add and reconfigure manufacturing capacity as needed in order to develop its current and future pipeline. By being modular as well as multi-modal, BMS reasons, the Houston campus will be flexible enough to evolve with the needs of the company and particularly patients into the future.<\/p>\n

BMS plans to create nearly 500 skilled jobs at the campus, which the company says will be designed to grow in scale, capability, and workforce for decades to come. The company also projected creating about 2,000 construction and other indirect jobs between 2027\u20132030 as the facility is built and brought online.<\/p>\n

Decision factors<\/p>\n

BMS, which is headquartered in Lawrenceville, NJ, said it selected Texas and Generation Park after conducting what it termed an extensive, competitive evaluation of multiple markets in the Central and Eastern United States.<\/p>\n

Among key factors in the decision, according to the company, were the emerging strength of Greater Houston\u2019s life sciences workforce, proximity to utilities and transportation infrastructure, an overall business climate conducive to long-term growth\u2014and available incentives.<\/p>\n

\u201cOur decision to build this state-of-the-art manufacturing campus in Houston, TX, reflects our confidence in the region\u2019s ability to support a world-class, digitally advanced supply operation,\u201d stated Karin Shanahan, a BMS EVP and the company\u2019s chief supply chain and operations officer.<\/p>\n

The state of Texas has extended a $4.89 million grant from its Texas Enterprise Fund to BMS and has designated the BMS Houston facility as a \u201cqualified project\u201d and thus eligible for incentives to be awarded through the Texas Jobs, Energy, Technology, and Innovation (JETI) program.<\/p>\n

\u201cWith lower operating costs and easy access to markets across the U.S. and the world, Texas drives affordability for consumers,\u201d added Gov. Greg Abbott (R), who is seeking re-election to a fourth term.<\/p>\n

The region\u2019s largest life-sci campus is the world\u2019s largest medical complex, the 1,345-acre, 54 million-square-foot Texas Medical Center (TMC), home to The University of Texas MD Anderson Cancer Center and Baylor College of Medicine\u2019s primary campus. The region is also home to six medical schools, three Tier One research universities, and specialized training programs through San Jacinto College\u2019s NIBRT-licensed Center for Biotechnology, Lone Star College, and Texas A&M\u2019s National Center for Therapeutics Manufacturing.<\/p>\n

Greater Houston is home to some 28,000 life sciences jobs, according to regional industry group BioHouston, and has about eight million square feet of lab space. BioHouston\u2019s chairman Jeff Wade told GEN that the region had scooped up about a half-billion dollars in VC funding between 2025 and the first half of 2026.<\/p>\n

\u201cBristol Myers Squibb\u2019s announcement is a tremendous win for Texas and the Houston region, further reinforcing our position as a premier destination for life sciences and advanced manufacturing,\u201d stated Steve Kean, president and CEO of the Greater Houston Partnership, a regional economic development group.<\/p>\n","protected":false},"excerpt":{"rendered":"A rendering of the $2.3 billion multi-modal manufacturing campus the Bristol Myers Squibb (BMS) plans to build in…\n","protected":false},"author":2,"featured_media":403331,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[45499,141345,108351,43643,68788,141346,141347,56,58,57,42517,24161,223,141348,92744],"class_list":["post-403330","post","type-post","status-publish","format-standard","has-post-thumbnail","category-houston","tag-biomanufacturing","tag-bioprocessing","tag-bristol-myers-squibb","tag-eli-lilly","tag-eli-lilly-and-company","tag-gen-edge","tag-genetic-engineering-and-biotechnology","tag-houston","tag-houston-headlines","tag-houston-news","tag-industry-news","tag-md-anderson-cancer-center","tag-news","tag-research-and-development","tag-topics"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/us-tx\/wp-json\/wp\/v2\/posts\/403330","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/us-tx\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/us-tx\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-tx\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-tx\/wp-json\/wp\/v2\/comments?post=403330"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/us-tx\/wp-json\/wp\/v2\/posts\/403330\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-tx\/wp-json\/wp\/v2\/media\/403331"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/us-tx\/wp-json\/wp\/v2\/media?parent=403330"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-tx\/wp-json\/wp\/v2\/categories?post=403330"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-tx\/wp-json\/wp\/v2\/tags?post=403330"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}